miRNAs, polyphenols, and chronic disease
- 20 November 2012
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 57 (1) , 58-70
Abstract
MicroRNAs (miRNAs) are small noncoding RNAs, approximately 18–25 nucleotides in length, that modulate gene expression at the posttranscriptional level. Thousands of miRNAs have been described, and it is thought that they regulate some aspects of more than 60% of all human cell transcripts. Several polyphenols have been shown to modulate miRNAs related to metabolic homeostasis and chronic diseases. Polyphenolic modulation of miRNAs is very attractive as a strategy to target numerous cell processes and potentially reduce the risk of chronic disease. Evidence is building that polyphenols can target specific miRNAs, such as miR‐122, but more studies are necessary to discover and validate additional miRNA targets.Keywords
Funding Information
- the Spanish Government (2008-00387/ALI)
This publication has 149 references indexed in Scilit:
- MicroRNA therapeutics in cardiovascular medicineEMBO Molecular Medicine, 2011
- The Lin28/let-7 Axis Regulates Glucose MetabolismCell, 2011
- Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cellsBiochemical Pharmacology, 2010
- Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetesDiabetologia, 2010
- Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic miceMammalian Genome, 2009
- The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese miceBiochemical and Biophysical Research Communications, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expressionHepatology, 2008
- The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancersGenes, Chromosomes and Cancer, 2008